Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

(2010) F. Zaja et al.   BLOOD

Does rituximab aggravate pre-existing hypogammaglobulinaemia?

(2010) L. Diwakar et al.   JOURNAL OF CLINICAL PATHOLOGY

Repeated courses of rituximab in chronic ITP: Three different regimens

(2009) Aisha Hasan et al.   AMERICAN JOURNAL OF HEMATOLOGY

Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin

(2009) Nichola Cooper et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP)

(2008) Kholood Alasfoor et al.   ANNALS OF HEMATOLOGY

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

(2008) B. Godeau et al.   BLOOD

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD

Rituximab in the treatment of autoimmune haematological disorders

(2008) Bernadette Garvey   BRITISH JOURNAL OF HAEMATOLOGY

Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response

(2008) Emilia Parodi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results

(2008) Marta Medeot et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura

(2008) Semir Pasa et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab

(2008) Brigitta U. Mueller et al.   PEDIATRIC BLOOD & CANCER

Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias

(2007) Aarati Rao et al.   PEDIATRIC BLOOD & CANCER